145 related articles for article (PubMed ID: 8142014)
1. Mutation and altered expression of p53 genes in experimental rat bladder tumor cells.
Jones RF; Matuszyk J; Debiec-Rychter M; Wang CY
Mol Carcinog; 1994 Feb; 9(2):95-104. PubMed ID: 8142014
[TBL] [Abstract][Full Text] [Related]
2. Activating missense mutations in Ha-ras-1 genes in a malignant subset of bladder lesions induced by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-[4-(5-nitro-2-furanyl)-2-thiazolyl]formamide.
Jones RF; Debiec-Rychter M; Zukowski K; Wang CY
Mol Carcinog; 1990; 3(6):393-402. PubMed ID: 2278634
[TBL] [Abstract][Full Text] [Related]
3. p53 mutation is infrequent and might not give a growth advantage in rat bladder carcinogenesis in vivo.
Asamoto M; Mann AM; Cohen SM
Carcinogenesis; 1994 Mar; 15(3):455-8. PubMed ID: 8118928
[TBL] [Abstract][Full Text] [Related]
4. Frequent mutations of the p53 gene and infrequent H- and K-ras mutations in urinary bladder carcinomas of NON/Shi mice treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Yamamoto S; Masui T; Murai T; Mori S; Oohara T; Makino S; Fukushima S; Tatematsu M
Carcinogenesis; 1995 Oct; 16(10):2363-8. PubMed ID: 7586136
[TBL] [Abstract][Full Text] [Related]
5. p53 mutations in transitional cell carcinomas of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Masui T; Dong Y; Yamamoto S; Takada N; Nakanishi H; Inada K; Fukushima S; Tatematsu M
Cancer Lett; 1996 Jul; 105(1):105-12. PubMed ID: 8689624
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in early neoplastic lesions of the urinary bladder in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Don I; Takada N; Ogawa K; Shirai T; Fukushima S
Carcinogenesis; 1994 Oct; 15(10):2379-81. PubMed ID: 7955081
[TBL] [Abstract][Full Text] [Related]
7. H-ras mutations in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide and sodium saccharin, sodium ascorbate, or related salts.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Fujii H; Pelling JC; Cohen SM
Cancer Res; 1991 Jul; 51(13):3471-5. PubMed ID: 2054786
[TBL] [Abstract][Full Text] [Related]
8. Mutations and expression of the p53 gene in rat bladder carcinomas and cell lines.
Asamoto M; Mann AM; Macatee TL; Cohen SM
Mol Carcinog; 1994 Apr; 9(4):236-44. PubMed ID: 8148056
[TBL] [Abstract][Full Text] [Related]
9. p53 gene mutation in N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder tumors and N-methyl-N-nitrosourea-induced colon tumors of rats.
Min H; Kudo E; Hino A; Yoshimoto K; Iwahana H; Itakura M; Izumi K
Cancer Lett; 1997 Jul; 117(1):81-6. PubMed ID: 9233835
[TBL] [Abstract][Full Text] [Related]
10. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 overexpression in rat two-stage bladder carcinogenesis and its relationship with oncogenes, tumor suppressor genes, and cell proliferation.
Lee CC; Yamamoto S; Wanibuchi H; Wada S; Sugimura K; Kishimoto T; Fukushima S
Cancer Res; 1997 Nov; 57(21):4765-76. PubMed ID: 9354438
[TBL] [Abstract][Full Text] [Related]
12. Direct DNA sequencing of the rat neu oncogene transmembrane domain reveals no mutation in urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl)nitrosamine, N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide or N-methyl-N-nitrosourea.
Masui T; Mann AM; Macatee TL; Garland EM; Okamura T; Smith RA; Cohen SM
Carcinogenesis; 1991 Oct; 12(10):1975-8. PubMed ID: 1682063
[TBL] [Abstract][Full Text] [Related]
13. Point mutation in codons 12 and 61 of the Ha-ras gene in rat urinary bladder carcinomas induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
Masui T; Mann AM; Garland EM; Okamura T; Johansson PL; Cohen SM
Mol Carcinog; 1990; 3(4):210-5. PubMed ID: 2206284
[TBL] [Abstract][Full Text] [Related]
14. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
[TBL] [Abstract][Full Text] [Related]
15. A functional and quantitative mutational analysis of p53 mutations in yeast indicates strand biases and different roles of mutations in DMBA- and BBN-induced tumors in rats.
Yamamoto K; Nakata D; Tada M; Tonoki H; Nishida T; Hirai A; Ba Y; Aoyama T; Hamada J; Furuuchi K; Harada H; Hirai K; Shibahara N; Katsuoka Y; Moriuchi T
Int J Cancer; 1999 Nov; 83(5):700-5. PubMed ID: 10521810
[TBL] [Abstract][Full Text] [Related]
16. Sequencing analysis of Ha-, Ki-, and N-ras genes in rat urinary bladder tumors induced by N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) and sodium saccharin.
Masui T; Mann AM; Borgeson CD; Garland EM; Okamura T; Fujii H; Pelling JC; Cohen SM
Teratog Carcinog Mutagen; 1993; 13(5):225-33. PubMed ID: 7905676
[TBL] [Abstract][Full Text] [Related]
17. Absence of ras oncogene activation in rat urinary bladder carcinomas induced by N-methyl-N-nitrosourea or N-butyl-N-(4-hydroxybutyl)nitrosamine.
Masui T; Mann AM; Macatee TL; Okamura T; Garland EM; Smith RA; Cohen SM
Carcinogenesis; 1992 Dec; 13(12):2281-5. PubMed ID: 1473235
[TBL] [Abstract][Full Text] [Related]
18. Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors.
Wei M; Wanibuchi H; Morimura K; Iwai S; Yoshida K; Endo G; Nakae D; Fukushima S
Carcinogenesis; 2002 Aug; 23(8):1387-97. PubMed ID: 12151359
[TBL] [Abstract][Full Text] [Related]
19. Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
Mann AM; Asamoto M; Chlapowski FJ; Masui T; Macatee TL; Cohen SM
Carcinogenesis; 1992 Sep; 13(9):1651-5. PubMed ID: 1394851
[TBL] [Abstract][Full Text] [Related]
20. Lack of involvement of p53 gene mutations in N-methyl-N-nitrosourea-induced bladder tumor progression in N-butyl-N-(4-hydroxybutyl)nitrosamine-treated rats and no suppression by indomethacin.
Ozaki M; Shibata MA; Takahashi S; Orita SI; Kawabe M; Shirai T
Cancer Lett; 1997 May; 115(2):249-55. PubMed ID: 9149132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]